Stock 301393 SUZHOU HIGHFINE BIOTECH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Suzhou Highfine Biotech Co., Ltd.

Equities

301393

CNE1000064T6

Commodity Chemicals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-09 pm EDT 		5-day change 1st Jan Change
54.42 CNY +1.00% Intraday chart for Suzhou Highfine Biotech Co., Ltd. +24.50% -9.32%
Apr. 25 Suzhou Highfine Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 09 Suzhou Highfine Biotech Co., Ltd. Proposes Final Cash Dividend for the Year 2023 CI

Valuation

Fiscal Period: December 2023 2024 2025
Capitalization 1 6,481 5,877 -
Enterprise Value (EV) 1 6,481 5,877 5,877
P/E ratio 56.1 x 30.2 x 22.9 x
Yield - - -
Capitalization / Revenue 16.7 x 8.75 x 6.62 x
EV / Revenue 16.7 x 8.75 x 6.62 x
EV / EBITDA 51.1 x 25.4 x 19.4 x
EV / FCF - - -
FCF Yield - - -
Price to Book 2.93 x 6.91 x 5.3 x
Nbr of stocks (in thousands) 108,000 108,000 -
Reference price 2 60.01 54.42 54.42
Announcement Date 4/8/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025
Net sales 1 - 388.8 671.6 888
EBITDA 1 - 126.7 231.2 302.3
EBIT 1 - 112.6 223.7 296.4
Operating Margin - 28.95% 33.32% 33.38%
Earnings before Tax (EBT) 1 - 112.5 223.6 296.2
Net income 1 129.4 98.97 194.2 257.3
Net margin - 25.46% 28.92% 28.97%
EPS 2 1.600 1.070 1.800 2.380
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 6/19/23 4/8/24 - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025
Net Debt - - - -
Net Cash position - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - - -
ROE (net income / shareholders' equity) - 8.14% 22.8% 23.2%
ROA (Net income/ Total Assets) - - - -
Assets 1 - - - -
Book Value Per Share 2 - 20.50 7.880 10.30
Cash Flow per Share 2 - 0.8100 1.460 1.900
Capex - - - -
Capex / Sales - - - -
Announcement Date 6/19/23 4/8/24 - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Suzhou Highfine Biotech Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
54.42
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Commodity Chemicals

1st Jan change Capi.
SUZHOU HIGHFINE BIOTECH CO., LTD. Stock Suzhou Highfine Biotech Co., Ltd.
-9.32% 806M
AIR LIQUIDE Stock Air Liquide
+5.97% 105B
SABIC Stock SABIC
-4.19% 63.99B
PT CHANDRA ASRI PACIFIC TBK Stock PT Chandra Asri Pacific Tbk
+51.90% 43.02B
WANHUA CHEMICAL GROUP CO., LTD. Stock Wanhua Chemical Group Co., Ltd.
+17.44% 39.28B
LYONDELLBASELL INDUSTRIES N.V. Stock LyondellBasell Industries N.V.
+6.78% 33.09B
WESTLAKE CORPORATION Stock Westlake Corporation
+12.88% 20.23B
NINGXIA BAOFENG ENERGY GROUP CO., LTD. Stock Ningxia Baofeng Energy Group Co., Ltd.
+15.64% 17.39B
HENGLI PETROCHEMICAL CO.,LTD. Stock Hengli Petrochemical Co.,Ltd.
+22.55% 15.45B
RONGSHENG PETROCHEMICAL CO., LTD. Stock Rongsheng Petrochemical Co., Ltd.
+7.34% 15.07B
Other Commodity Chemicals
  1. Stock Market
  2. Equities
  3. 301393 Stock
  4. Financials Suzhou Highfine Biotech Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW